Hogan Lovells advised CatalYm GmbH on the deal.CatalYm GmbH, a Munich-based life sciences company, completed a significant USD150 million venture capital funding round. The oversubscribed funding…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
